The mission of NYU Langone’s Venous Thromboembolic Center (VTEC) is to seamlessly deliver advanced detection, care, and management services for patients experiencing a venous thromboembolism, commonly known as a blood clot.
We are among a few select centers nationwide that have a team of clinicians and scientists working together to streamline high-quality patient care and conduct innovative research, making us a premier resource for education about venous thromboembolic disease.
We’ve created standardized, evidenced-based guidelines for screening, preventing, diagnosing, and managing blood clots that are used throughout NYU Langone. We are able to track every patient found to have a blood clot while being treated at NYU Langone, enabling an expert from VTEC to quickly deliver customized patient care.
A blood clot can occur suddenly, without warning, and can be fatal in nearly one-third of patients. Timely, efficient treatment is critical for preventing serious complications and saving your life.
Our center is currently working with NYU Langone’s world-class scientists and researchers to conduct a large study with the goal of increasing our understanding of the risk factors for blood clots, and improving prevention and treatment. We aim to have a recognizable genetic handprint for blood clots in the form of a blood test that can warn us which patients may develop forms of blood clots, such as deep vein thrombosis or pulmonary embolisms, so we can offer the best preventive treatment during your stay in the hospital and beyond.
VTEC is also at the forefront of providing education to the larger medical community, creating the nation’s first fellowship program dedicated solely to venous thromboembolic disease.
For more information or to make an appointment, please call 844-NYU-VTEC (844-698-8832).